Our Company was originally incorporated as Private Limited, under the Companies Act, 2013 (“Companies Act”) in the name and style of “Avience Biomedicals Private Limited” on December 23, 2019, under the provisions of the Companies Act, 2013 vide Certificate of ... Read more
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 4,09,800 (28.19%) |
| Market Makers | 82,200 (5.65%) |
| Non Institutional Investors | 2,07,000 (14.24%) |
| Qualified Institutional Buyers (QIBs) | 2,73,600 (18.82%) |
| Retail Individual Investors (RIIs) | 4,81,200 (33.1%) |
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2025 | 29.54 Cr | 5.14 Cr | 16.49 Cr |
| 31 Mar 2024 | 16.64 Cr | 1.98 Cr | 2.77 Cr |
| 31 Mar 2023 | 10.93 Cr | 70.78 Lakh | 78.52 Lakh |
1. Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
2. Funding the working capital requirement of our Company
3. General Corporate Purpose
1. Mr. Dharam Deo Choudhary
2. Mr. Ram Nagina Choudhary
3. Mr. Janardan Pal
4. Mrs. Deepa Choudhary
The Indian Pharmaceuticals industry plays a prominent role in the global pharmaceuticals industry. Major segments of Indian Pharmaceutical Industry include diagnostic kits, medical devices etc.
The healthcare and medical device sectors in India have grown significantly in the last decade. ... Read more
When does Avience Biomedicals Ltd. IPO opens and closes?
What is the size of Avience Biomedicals Ltd. IPO?
What is the price range of Avience Biomedicals Ltd. IPO?
What is the minimum investment and lot size required for the Avience Biomedicals Ltd. IPO?
When is Avience Biomedicals Ltd. IPO listing date?
What is the objective of Avience Biomedicals Ltd. IPO?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article